Wird geladen...
Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer
Ovarian cancer remains the leading cause of death due to gynecologic malignancies. Most patients present with advanced disease at the time of diagnosis. Although many have a good initial response to surgical debulking and platinum-based chemotherapy, relapse is common, with the eventual development...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2011
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3221001/ https://ncbi.nlm.nih.gov/pubmed/21322756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.10.100 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|